Visteon Amends 10-Q to Disclose CEO's 10b5-1 Trading Plan

Ticker: VC · Form: 10-Q/A · Filed: Nov 4, 2025 · CIK: 1111335

Visteon CORP 10-Q/A Filing Summary
FieldDetail
CompanyVisteon CORP (VC)
Form Type10-Q/A
Filed DateNov 4, 2025
Risk Levelmedium
Pages4
Reading Time5 min
Sentimentmixed

Sentiment: mixed

Topics: 10-Q/A, Executive Compensation, Insider Trading Plans, Rule 10b5-1, Corporate Governance, Visteon, Automotive Technology

Related Tickers: VC

TL;DR

**Visteon's 10-Q/A reveals top executives, including the CEO, are setting up pre-planned stock sales, a move that could signal a lack of strong insider conviction despite being routine.**

AI Summary

Visteon Corporation filed an Amendment No. 1 on Form 10-Q/A on November 4, 2025, to its Quarterly Report for the period ended September 30, 2025. This amendment specifically addresses the inadvertent omission of disclosure regarding a Rule 10b5-1 trading arrangement entered into by Sachin S. Lawande, Director, President, and Chief Executive Officer. Mr. Lawande's plan, adopted on July 31, 2025, allows for the exercise and subsequent sale of up to 99,874 shares of common stock underlying stock options, with an expiration date of July 24, 2026. Additionally, the amendment disclosed similar Rule 10b5-1 plans for Jerome Rouquet, Senior Vice President and Chief Financial Officer, involving 14,067 shares (9,392 common stock sales and 4,675 option exercises/sales) adopted on August 14, 2025, expiring February 20, 2026, and Qais Sharif, Senior Vice President & General Manager of the Americas, for 2,200 shares adopted on September 24, 2025, expiring May 20, 2026. New certifications from the principal executive officer and principal financial officer were also filed, as required by Rule 12b-15 of the Exchange Act, but financial statements were not included or amended.

Why It Matters

This amendment provides crucial transparency regarding executive stock sales, which can influence investor perception of insider confidence. The disclosure of Rule 10b5-1 plans for CEO Sachin S. Lawande (99,874 shares), CFO Jerome Rouquet (14,067 shares), and SVP Qais Sharif (2,200 shares) allows investors to understand pre-planned stock transactions, mitigating concerns about opportunistic selling. While these are pre-scheduled, a significant volume of planned sales, especially from top executives, could be interpreted as a signal about future company performance or valuation, potentially impacting Visteon's competitive standing in the automotive technology sector.

Risk Assessment

Risk Level: medium — The risk level is medium because the filing corrects an omission regarding executive trading plans, specifically a Rule 10b5-1 arrangement for CEO Sachin S. Lawande involving 99,874 shares. While these plans are pre-scheduled and intended to avoid insider trading accusations, the sheer volume of shares involved from top executives (totaling 116,141 shares across three officers) could be perceived negatively by the market, suggesting insiders are locking in gains.

Analyst Insight

Investors should monitor the actual execution of these Rule 10b5-1 plans and consider the aggregate volume of shares being sold by Visteon's top executives. While these are pre-planned, a significant outflow could warrant a deeper look into Visteon's future growth prospects and current valuation relative to its peers.

Executive Compensation

NameTitleTotal Compensation
Sachin S. LawandeDirector, President and Chief Executive Officer
Jerome RouquetSenior Vice President and Chief Financial Officer
Qais SharifSenior Vice President & General Manager of the Americas

Key Numbers

Key Players & Entities

FAQ

Why did Visteon Corporation file an Amendment No. 1 on Form 10-Q/A?

Visteon Corporation filed the Amendment No. 1 on Form 10-Q/A to correct an inadvertent omission from its original 10-Q filing. The amendment specifically adds disclosure regarding a Rule 10b5-1 trading arrangement entered into by Sachin S. Lawande, the Director, President, and Chief Executive Officer.

What is a Rule 10b5-1 trading arrangement and who at Visteon has one?

A Rule 10b5-1 trading arrangement allows company insiders to set up a pre-planned schedule for buying or selling company stock to avoid accusations of insider trading. At Visteon, Sachin S. Lawande (CEO), Jerome Rouquet (CFO), and Qais Sharif (SVP & GM of the Americas) have adopted such plans.

How many shares are involved in CEO Sachin S. Lawande's Rule 10b5-1 plan at Visteon?

Sachin S. Lawande's Rule 10b5-1 Trading Plan provides for the exercise of up to 99,874 stock options and subsequent sale of up to 99,874 shares of common stock underlying those options.

When was Visteon CEO Sachin S. Lawande's Rule 10b5-1 plan adopted and when does it expire?

Sachin S. Lawande's Rule 10b5-1 plan was adopted on July 31, 2025, and is set to expire on July 24, 2026.

What are the details of CFO Jerome Rouquet's Rule 10b5-1 plan at Visteon?

Jerome Rouquet's Rule 10b5-1 Trading Plan, adopted on August 14, 2025, provides for the sale of 9,392 shares of common stock and the exercise and subsequent sale of up to 4,675 shares of common stock underlying stock options, totaling 14,067 shares, expiring February 20, 2026.

Are new financial statements included in Visteon's 10-Q/A filing?

No, new financial statements have not been included in this Amendment No. 1 on Form 10-Q/A. The filing explicitly states that it does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K.

What is the total number of shares outstanding for Visteon Corporation as of October 16, 2025?

As of October 16, 2025, Visteon Corporation had outstanding 27,285,922 shares of common stock.

What is the significance of the certifications filed with Visteon's 10-Q/A?

New certifications by Visteon's principal executive officer and principal financial officer are filed as exhibits to this Amendment, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act. These certifications confirm the accuracy of the information in the amended filing, as required by regulatory standards.

How might the disclosure of executive 10b5-1 plans impact Visteon investors?

The disclosure of executive 10b5-1 plans provides transparency for Visteon investors regarding pre-scheduled stock transactions. While these plans are designed to prevent insider trading, a significant volume of planned sales, such as the 99,874 shares from the CEO, could be interpreted by some investors as a signal about future company performance or valuation, potentially influencing investment decisions.

Does this Visteon 10-Q/A reflect events after the original filing date?

No, this Amendment No. 1 on Form 10-Q/A does not reflect events occurring after the filing of the Original Filing on October 23, 2025, nor does it modify or update disclosures affected by subsequent events. It speaks as of the original filing date, except for the specific items amended.

Industry Context

Visteon Corporation operates in the automotive technology sector, specifically focusing on cockpit electronics, connected car, and autonomous driving solutions. The industry is characterized by rapid technological advancements, intense competition from both established Tier 1 suppliers and new entrants, and increasing demand for sophisticated in-vehicle digital experiences. Key trends include the shift towards software-defined vehicles, electrification, and advanced driver-assistance systems (ADAS).

Regulatory Implications

The inadvertent omission of executive trading plan disclosures highlights the importance of meticulous compliance with SEC reporting requirements, particularly Rule 10b5-1 and Rule 12b-15. Failure to properly disclose such arrangements can lead to scrutiny from regulators and potential penalties. The filing of new certifications underscores the ongoing commitment to accurate and timely reporting.

What Investors Should Do

  1. Review the specific details of the Rule 10b5-1 plans for CEO Sachin S. Lawande, CFO Jerome Rouquet, and SVP Qais Sharif, noting the number of shares involved and expiration dates, to understand potential future selling pressure.
  2. Note the filing of new executive certifications, which indicates a correction of a prior omission and reinforces compliance procedures.
  3. Monitor Visteon's ongoing compliance with SEC disclosure rules, as the amendment addresses an inadvertent omission, suggesting a need for vigilance in reporting.

Key Dates

Glossary

Rule 10b5-1 trading arrangement
A written plan adopted by an insider (like a company executive) for trading securities. It must be adopted when the insider does not possess material non-public information and specifies the number of shares, prices, and dates for trades, providing an affirmative defense against insider trading allegations. (This filing amends the previous report to include details of such plans adopted by key executives, which were inadvertently omitted.)
Form 10-Q/A
An amendment to a previously filed Form 10-Q (Quarterly Report). It is used to correct or supplement information previously reported. (Visteon is filing this amendment to add previously omitted disclosures regarding executive trading plans.)
Rule 12b-15
A rule under the Securities Exchange Act of 1934 that governs the requirements for filing amendments to registration statements and reports, including the need for new certifications. (This rule necessitates the filing of new certifications by the CEO and CFO with this amendment.)
Stock options
Contracts that give the holder the right, but not the obligation, to buy or sell a stock at a predetermined price (the strike price) within a specified period. (The CEO's and CFO's trading plans involve the exercise of stock options and subsequent sale of the underlying shares.)

Year-Over-Year Comparison

This filing is an amendment to the original Form 10-Q for the period ended September 30, 2025, and does not contain updated financial statements or comparative year-over-year financial metrics. The primary change is the addition of disclosures regarding Rule 10b5-1 trading plans for key executives, which were inadvertently omitted from the initial filing. No new financial data or operational updates are presented in this amendment.

Filing Stats: 1,134 words · 5 min read · ~4 pages · Grade level 12.8 · Accepted 2025-11-04 17:16:07

Filing Documents

Other Information

Item 5. Other Information The Company's directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of the Company's shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended September 30, 2025, the following officer(s) took the following action. Name Title Action Intended to satisfy the affirmative defense of Rule 10b5-1? Date Aggregate Number of Shares to be sold Expiration Date Qais Sharif Senior Vice President & General Manager of the Americas Adoption Yes 9/24/2025 2,200 5/20/2026 Jerome Rouquet Senior Vice President and Chief Financial Officer Adoption Yes 8/14/2025 14,067 2/20/2026 Sachin S. Lawande Director, President and Chief Executive Officer Adoption Yes 7/31/2025 99,874 7/24/2026 Mr. Rouquet's Rule 10b5-1 Trading Plan provides for the (i) sale of 9,392 shares of common stock and (ii) exercise of up to 4,675 stock options and subsequent sale of up to 4,675 shares of common stock underlying such stock options. Mr. Lawande's Rule 10b5-1 Trading Plan provides for the exercise of up to 99,874 stock options and subsequent sale of up to 99,874 shares of common stock underlying such stock options. 3

Exhibits

Item 6. Exhibits The exhibits listed on the "Exhibit Index" are filed with this report or incorporated by reference as set forth therein. Exhibit Index Exhibit No. Description 31.1 Rule 13a-14(a) Certification of Chief Executive Officer dated November 4 , 2025. 31.2 Rule 13a-14(a) Certification of Senior Vice President, Chief Financial Officer dated November 4 , 2025. 101 iXBRL (Inline Extensible Business Reporting Language) for the information under Part II, "Item 5, Other Information" of this Amendment No. 1 on Form 10-Q/A 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). 4 Pursuant to the requirements of the Securities Exchange Act of 1934, Visteon Corporation has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized. VISTEON CORPORATION By: /s/ COLLEEN E. MYERS Colleen E. Myers Vice President and Chief Accounting Officer Date: November 4, 2025 5

View Full Filing

View this 10-Q/A filing on SEC EDGAR

View on Read The Filing